Company Overview
LINEAGE CELL THERAPEUTICS, INC.
LCTXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
15M
2025 FY
Net Income
-64M
2025 FY
Shares Outstanding
230M
2025 FY
EPS
-0.28USD
2025 FY
Company Information
SIC Code
2836
CIK Code
876343
Exchange
NYSE
Location
US